Schmid John P. Insider Trading Activity

Average Profitability
34.06%
Insider Buys Quantity
7
Insider Buys Sum
$149,868.52
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Schmid John P.

According to the SEC Form 4 filings, Schmid John P., being in a position of

  1. director at AnaptysBio, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 20645 shares for $1.16M,
    over all time since 2026-03-30, has bought 0 shares, and sold 20645 shares for $1.16M.

Biography of Schmid John P.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $1,158,4511100

Comparison of Insiders on Amount of Buys and Sells

2026-03-30SaleAnaptysBio, Inc.
ANAB
director
20,645
0.0728%
$56.11$1.16M+49.08%
2024-08-12PurchaseXeris Biopharma Holdings, Inc.
XERS
director
4,515
0.003%
$2.25$10,147+62.67%
2024-08-09PurchaseXeris Biopharma Holdings, Inc.
XERS
director
4,285
0.0029%
$2.37$10,134+57.33%
2024-05-10PurchaseXeris Biopharma Holdings, Inc.
XERS
director
5,400
0.004%
$1.91$10,314+80.68%
2024-03-25PurchaseDesign Therapeutics, Inc.
DSGN
director
17,809
0.0318%
$3.74$66,606+27.01%
2024-03-22PurchaseDesign Therapeutics, Inc.
DSGN
director
9,156
0.0156%
$3.62$33,133+25%
2024-03-14PurchaseXeris Biopharma Holdings, Inc.
XERS
director
4,500
0.0032%
$2.16$9,720+32.63%
2023-11-16PurchaseXeris Biopharma Holdings, Inc.
XERS
director
6,500
0.0045%
$1.51$9,815+51.59%
Total: 8
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.